Soaring demand and limited supply defined 2024, breaking records in both residential and office markets, with further increases expected in 2025. Increased supply pipeline and regulatory updates set t ...

Biocon has reported a consolidated net profit of Rs 25 crore in Q3 FY25, which is significantly lower as compared with the PAT of Rs 660 crore posted in Q3 FY24.

Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose ...